The strongest quantum companies may not necessarily own the most patents. They will own - or credibly influence - the few technical control points that the market cannot easily route around. In a field where architectures, standards and winning business models remain unsettled, defensibility comes from a deliberately layered portfolio: patents where disclosure buys exclusion; trade secrets where secrecy compounds advantage; and contracts, data rights, copyright and know-how controls that prevent value leaking between the cracks. The task is not to protect everything but to protect what the future ecosystem is likely to need to pass through.
The market will reward control, not accumulation
Quantum innovation is not one market but a stack of interdependent bets: hardware architectures, error correction, control systems, enabling materials, photonics, networking, software tools and algorithms. It remains uncertain which layers will capture the greatest share of value, or which architectures will become dominant. That uncertainty is not a reason to file indiscriminately. It is a reason to be more strategic.
6 moves that create defensible advantage
Start where the stack is hardest to escape
Some inventions improve a product. Others become infrastructure. The latter deserve disproportionate attention because they can sit beneath several products, customers and generations of technology. The point is not to predict which technology will prevail, but to identify assets with reach beyond a single product or technical iteration.
Hunt at the seams
The most valuable IP is often found not inside a single discipline, but where two difficult systems must work together. These seams are technically demanding, commercially sticky and frequently overlooked by teams organised in silos.
Match the protection tool to the asset
A patent-only strategy is not an IP strategy; it is a filing programme. Quantum businesses create value through inventions, software, tacit know-how and operating discipline. Each asset should be protected by the mechanism that best preserves its commercial advantage.
Asset typeTypical quantum examples
Patent protection is more attractive where third-party use can be detected, reverse engineering is feasible, the commercial life justifies disclosure and cost, or publication supports licensing and standards influence. Secrecy may be more valuable where use is difficult to detect, the process can remain internal, the advantage may outlast a patent lifecycle, or disclosure would teach competitors how to reproduce it.
File to the commercial roadmap - not the publication calendar
Patents that are relatively straightforward to obtain are not necessarily the patents a business will be grateful to own. Scientific novelty matters but filing decisions should also be tested against commercial consequences. Broad early filing can still be rational where disclosure is imminent, technical direction remains fluid or later claim development is available. But urgency should not displace discipline: an early filing should preserve strategically valuable options.
Treat freedom to operate as a design input
FTO is too often treated as a legal clearance exercise performed just before launch. By then, expensive choices may have been made. Patentability asks whether the company may obtain rights over an invention. Freedom to operate asks whether commercialisation may infringe third-party rights. Strategic control asks whether the resulting portfolio gives the company meaningful commercial leverage. These questions are related, but they are not interchangeable.
Own selectively; negotiate from strength everywhere else
For each critical capability decide whether to own, influence, license, access through a partner, or acquire it. Few quantum companies will need - or be able - to own every important layer of the stack. Nor should they try.
A practical control-point framework
Not every important capability must sit on the balance sheet, but every important dependency needs a conscious strategy.
When it may be appropriate
core differentiation or dependency
Portfolio implication
deep patent coverage and trade-secret controls
When it may be appropriate
standards or ecosystem interfaces
Portfolio implication
strategic filings, standards participation and publication discipline
When it may be appropriate
third-party technology is efficient to access
Portfolio implication
FTO review, durable licence scope and improvement rights
When it may be appropriate
complementary capability is required
Portfolio implication
clear background/foreground IP and exit provisions
When it may be appropriate
capability is strategically necessary but hard to build
Portfolio implication
diligence on title, validity, encumbrances and integration
How good portfolios quietly become weak ones
Portfolio weakness rarely announces itself. It accumulates through reasonable-looking decisions made in isolation: a filing rushed before publication, a collaboration signed without clean IP boundaries, or a technically elegant claim with no strategic role. Warning signs include:
filing broadly before the technology and commercial proposition have stabilised
protecting isolated inventions without a coherent portfolio architecture
failing to define background IP, foreground IP and improvement ownership in collaborations
measuring success by patent count
The questions serious capital will ask
Investors are not counting certificates on the wall. They are testing whether the IP estate survives contact with commercial reality. Expect scrutiny of:
executed assignments; founder, employee and consultant terms; university and prior-employer releases; inventor records; and clear schedule of encumbrances.
a portfolio map linking patent families, trade secrets, data and know-how to products, control points, jurisdictions, competitors and the commercial roadmap.
search and monitoring records, material third-party rights, design-around analysis, licence scope, standards exposure and contingency plans for critical suppliers.
evidence that rights support customer adoption, licensing, partnerships, enforcement and exit value.
The question that should organise the portfolio
Which control points in the future quantum value chain must we own, where must we shape the rules, and where can we rely on access without surrendering leverage?
That question changes the conversation. It moves IP from the end of the innovation process to the centre of corporate strategy - and replaces a collection of rights with a portfolio capable of shaping the market.
The Latest Thought Leadership pieces in the Content Hub
System architecture in quantum computing – history repeating itself?
December 24, 2025
This article explores the evolution of system architecture in quantum computing, drawing parallels with the early days of classical computing. It discusses the current challenges in quantum hardware, the emergence of quantum instruction set architectures (ISAs), and the potential for a RISC vs. CISC debate similar to that in classical computing. The piece highlights opportunities for innovation and intellectual property, suggesting that the choices made now could shape the future landscape of quantum technologies and licensing.
Quantum Sensors: What are they and why do they matter to healthcare?
May 19, 2025
The UN says we are in a year of quantum, celebrating 100 years since the development of quantum mechanics. While quantum computing is often the main talking point, the other areas of quantum tech,...
Ask the Experts: Can I get a patent for my invention?
17 August 2021
In the first article in this series, we introduced patent attorneys, and suggested that ‘How do I get a patent’ may not be the first question to ask a patent attorney.
Ask the Experts: Can a patent attorney help your business?
10 August 2021
If you have watched the BBC programme ‘Dragons Den', you'll almost certainly have heard entrepreneurs asked about intellectual property rights, such as patents, design rights, trademarks and so on.
Should I get my Patent Application to Grant as Fast as Possible?
28 July 2021
Why do patents take so long to grant?Progressing a patent family through to grant can take a notoriously long amount of time, particularly when an applicant is looking to protect their invention in a...
How could internal combustion engines help drive decarbonisation?
22 July 2021
Last week, the UK Government announced that sales of new petrol and diesel heavy goods vehicles (HGVs) will be banned by 2040. The UK's Road Haulage Association supports the aim, but in a press...
Digital event: Reality check for patenting computer-implemented simulations at the EPO
21 May 2021
Join us for a digital event on the 2 June.In its decision G1/19 (Simulations), the Enlarged Board of Appeal (EBoA) of the European Patent Office (EPO) addresses the patentability of...
Digital event: Patent enablement in the UK – the judgments in the Regeneron and Illumina cases
09 April 2021
Join us for a digital event on the 21 April where we will be covering what you need to know about the requirement of patent enablement in the UK – the Supreme Court decision in Regeneron and the High...
Digital event: What you need to know about the new EPO Guidelines for Examination
23 March 2021
Join us for a digital event on Tuesday 30th March covering what you need to know about the new EPO Guidelines and current EPO practice.This webinar hosted by Gareth Probert and Darren Smyth will give...
International Women’s Day 2021: Q&A with Justyna Strzeszynska, founder & CEO of Joii
08 March 2021
This year, the International Women’s Day theme is ‘choose to challenge’ with a focus on challenging change to create a gender equal world.The day marks a call to action for accelerating women’s...
International Women’s Day 2021: Q&A with Kate Bache, co-founder & managing director of Health and Her
08 March 2021
This year, the International Women’s Day theme is ‘choose to challenge’ with a focus on challenging change to create a gender equal world.The day marks a call to action for accelerating women’s...
National Careers Week: How I started my career in IP by Tom Swift
05 March 2021
In support of National Careers Week, trainee patent attorney, Tom Swift discusses his journey into IP and gives advice to others looking to start a career in IP.
Following the end of Brexit here at EIP we can advise on the protection of your designs and trademarks.We can represent your design applications at the UK IPO, EU IPO and USPTO through our offices in...
Brexit – what happens to your EU rights after the Transition Period?
25 November 2020
As we approach the end of the transition period, which expires on 31 December 2020, it is timely to provide an update and reminder about the impact of Brexit on EU Trademarks and Registered Community...
BioWednesday Webinar Report: Enabling Access to Medical Technologies - Compulsory Licensing, TRIPS and FRAND
12 June 2020
On 20th May 2020 EIP Life partners Andy Sharples and Monika Rai joined One Nucleus’ BioWednesday webinar.EIP have created an event report that covers the webinar in more detail.
Intel has built a cellular portfolio of 5G patent assets at some pace. The industry should take note, says James Seymour in this article in the September 2019 issue of Intellectual Property Magazine.
.png)
